GBT2104-131 A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants with Sickle Cell Disease (SCD) Experiencing Vaso-occlusive Crisis (VOCs)
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Global Blood Therapeutics, Inc.
Start Date
June 4, 2021
End Date
May 31, 2024
Administered By
Medicine, Hematology
Awarded By
Global Blood Therapeutics, Inc.
Start Date
June 4, 2021
End Date
May 31, 2024